B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.
about
Autoantibodies to Potassium Channel KIR4.1 in Multiple SclerosisSerpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healingCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisBiomarkers in Multiple Sclerosis: An Up-to-Date OverviewGenomic regions associated with multiple sclerosis are active in B cellsSystemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation.Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 inductionIL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destructionOxidative stress, prooxidants, and antioxidants: the interplay.Adaptive human immunity drives remyelination in a mouse model of demyelinationBiomarker studies in multiple sclerosis: from proteins to noncoding RNAs.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15.Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
P2860
Q21129427-1E9F1CBB-9DA8-4801-9773-EDA01801ABFFQ24563950-74C3351E-19EE-4800-B7DD-4D0F54D2BE15Q26771459-8181C921-8481-4C95-9CF9-99A66ED8506EQ27496017-9F12AA03-B7AA-4EB4-B531-D538775C575EQ28731577-BCCCF64E-B066-449D-A960-2F9C97DB6A9CQ34463760-7B89C039-1967-4C07-87AB-4201F7A5C44AQ35058643-78D24DA2-188E-4BD1-92E1-341DCC46830BQ36718160-79A2A7E0-C4B0-4BD5-88E7-A7BAE9A04B28Q37364736-AA90DF37-D84A-4E67-AD34-B0CD503C2666Q37577377-65B157DD-EEC4-4630-8128-69231736F1ADQ37739895-B9409F86-44A2-4175-8DF3-05E31E0370B7Q38234717-AD3E7156-D945-42AE-8541-4AE107EFA493Q39084950-1006DA41-6456-47B6-BA04-A3DCF4214CBEQ41051473-5BE455B0-91F2-406C-8ED0-E7C12C8C751BQ41079121-1912A79A-B3CC-4F43-97F6-DDABAF6A4066Q41091865-59C9064B-44E1-4FBD-A1C6-89EEE2660A48Q50934354-815EFDBD-12E6-4C19-8C1F-CA8CD5E6AB00Q52145132-1999C32D-EE25-48B6-98E8-260F42CFD478
P2860
B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@en
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@nl
type
label
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@en
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@nl
prefLabel
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@en
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@nl
P2093
P2860
P356
P1476
B cell-derived IL-15 enhances ...... n multiple sclerosis patients.
@en
P2093
Alexandre Prat
Alma Nazlie Mohebiany
Diane Beauseigle
Igal Ifergan
Nathalie Arbour
Pierre Duquette
Raphael Schneider
P2860
P304
P356
10.4049/JIMMUNOL.1100885
P407
P577
2011-09-12T00:00:00Z